EGFR and neoplasm: The significant difference in tumor status between the GA + AA and GG genotypes with EGFR wild-type status was also observed when all patients were analyzed, as 43.7% of those with the GA + AA genotype had advanced (T3/T4) tumors compared with 28.2% with the GG genotype (p = 0.021).